TIMOTHY CORBETT: Open Payments
NPI 1932209335 · FARMVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 26 payments from 9 companies in 2025. Trend: 2023 $746 · 2024 $1,161 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $204 |
| Corcept Therapeutics | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Amgen Inc. | 3 | $44 |
| ABBVIE INC. | 2 | $39 |
| Novo Nordisk Inc | 1 | $27 |
| Astellas Pharma US Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
Products named: FARXIGA, Korlym, JARDIANCE, AIRSUPRA, BREZTRI, OTEZLA, QULIPTA, Wegovy.
Industry payments across VA — which companies pay providers there.
